Screens in human melanoma cells have revealed mechanisms mediating susceptibility to in vitro CD8+ T cell killing, including an apelin receptor (APLNR) required for interferon gamma (IFNγ) susceptibility and components of the TNF pathway including TRAF2 (84, 105). This evidence concerns the gene IFNG and melanoma.